Nexalin Technology Stock Last Dividend Paid
| NXL Stock | USD 4.18 0.09 2.11% |
Nexalin Technology fundamentals help investors to digest information that contributes to Nexalin Technology's financial success or failures. It also enables traders to predict the movement of Nexalin Stock. The fundamental analysis module provides a way to measure Nexalin Technology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nexalin Technology stock.
Nexalin | Last Dividend Paid |
Nexalin Technology Company Last Dividend Paid Analysis
Nexalin Technology's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Nexalin Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for Nexalin Technology is extremely important. It helps to project a fair market value of Nexalin Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Nexalin Technology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nexalin Technology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nexalin Technology's interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Nexalin Dividend Paid And Capex Coverage Ratio
Dividend Paid And Capex Coverage Ratio |
|
Based on the recorded statements, Nexalin Technology has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Nexalin Technology ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nexalin Technology's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nexalin Technology's managers, analysts, and investors.Environmental | Governance | Social |
Nexalin Fundamentals
| Return On Equity | -2.02 | ||||
| Return On Asset | -1.19 | ||||
| Operating Margin | (48.32) % | ||||
| Current Valuation | 51.98 M | ||||
| Shares Outstanding | 12.86 M | ||||
| Shares Owned By Insiders | 23.29 % | ||||
| Shares Owned By Institutions | 2.40 % | ||||
| Number Of Shares Shorted | 622.63 K | ||||
| Price To Book | 11.08 X | ||||
| Price To Sales | 365.74 X | ||||
| Revenue | 110.75 K | ||||
| Gross Profit | 958.14 K | ||||
| EBITDA | (5.69 M) | ||||
| Net Income | (4.65 M) | ||||
| Cash And Equivalents | 291.33 K | ||||
| Cash Per Share | 0.06 X | ||||
| Total Debt | 4.46 K | ||||
| Current Ratio | 0.20 X | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | (3.84 M) | ||||
| Short Ratio | 0.56 X | ||||
| Earnings Per Share | (0.65) X | ||||
| Target Price | 3.0 | ||||
| Beta | 3.57 | ||||
| Market Capitalization | 54.92 M | ||||
| Total Asset | 3.63 M | ||||
| Retained Earnings | (77.04 M) | ||||
| Working Capital | 3 M | ||||
| Net Asset | 3.63 M |
About Nexalin Technology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nexalin Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nexalin Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nexalin Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nexalin Technology Piotroski F Score and Nexalin Technology Altman Z Score analysis. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.65) | Revenue Per Share 0.02 | Quarterly Revenue Growth (0.24) | Return On Assets (1.19) | Return On Equity (2.02) |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.